Journal of Tissue Viability
Volume 19, Issue 2 , Pages 77-83 , May 2010

Candidate biomarkers for deep tissue damage from molecular biological and biochemical aspects

  • Takeo Minematsu

      Affiliations

    • Department of Advanced Skin Care, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo 113-0033, Japan
    • ,
  • Gojiro Nakagami

      Affiliations

    • Department of Gerontological Nursing/Wound Care Management, Division of Health Science and Nursing, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
    • ,
  • Yunita Sari

      Affiliations

    • Department of Gerontological Nursing/Wound Care Management, Division of Health Science and Nursing, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
    • ,
  • Tomoko Akase

      Affiliations

    • Department of Gerontological Nursing/Wound Care Management, Division of Health Science and Nursing, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
    • ,
  • Junko Sugama

      Affiliations

    • Department of Advanced Skin Care, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo 113-0033, Japan
    • Department of Clinical Nursing, Division of Health Sciences, Graduate School of Medical Science, Kanazawa University, Ishikawa, Japan
    • ,
  • Takashi Nagase

      Affiliations

    • Department of Gerontological Nursing/Wound Care Management, Division of Health Science and Nursing, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
    • ,
  • Hiromi Sanada

      Affiliations

    • Department of Gerontological Nursing/Wound Care Management, Division of Health Science and Nursing, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
    • Corresponding Author InformationCorresponding author. Tel./fax: +81 3 5841 3419.

References 

  1. Ankrom MA, Bennett RG, Springle S, Langemo D, Black J, Berlowitz D, et al. Pressure-related deep tissue injury under intact skin and current pressure ulcer staging systems. Adv Skin Wound Care. 2005;18:35–42
  2. Black J, Baharestani M, Cuddigan J, Dorner B, Edsberg L, Langemo D, et al. National pressure ulcer advisory panel's updated pressure ulcer staging system. Urol Nurs. 2007;27:144–150
  3. Black J, Black S. Deep tissue injury. Wounds. 2003;15:380
  4. Nagase T, Koshima I, Maekawa T, et al. Ultrasonographic evaluation of an unusual peri-anal induration: a possible case of deep tissue injury. J Wound Care. 2007;16:365–367
  5. Aoi N, Yoshimura K, Kadono T, Nakagami G, Iizuka S, Higashino T, et al. Ultrasound assessment of deep tissue injury in pressure ulcers: possible prediction of pressure ulcer progression. Plast Reconstr Surg. 2009;124:540–550
  6. Elsner JJ, Gefen A. Is obesity a risk factor for deep tissue injury in patients with spinal cord injury?. J Biomech. 2008;41:3322–3333
  7. Berlowitz DR, Brienza DM. Are all pressure ulcers the result of deep tissue injury? A review of the literature. Ostomy Wound Manage. 2007;53:34–38
  8. Bouten CV, Oomens CW, Baajiens FP, Bader DL. The etiology of pressure ulcers: skin deep or muscle bound?. Arch Phys Med Rehabil. 2003;84:616–619
  9. Stekelenburg A, Gawlitta D, Bader DL, Oomens CW. Deep tissue injury: how deep is our understanding?. Arch Phys Med Rehabil. 2008;89:1410–1413
  10. Stekelenburg A, Strijkers GJ, Parusel H, Bader DL, Nicolay K, Oomens CW. Role of ischemia and deformation in the onset of compression-induced deep tissue injury: MRI-based studies in a rat model. J Appl Phys. 2007;102:2002–2011
  11. Peirce SM, Skalak TC, Rodeheaver GT. Ischemia-reperfusion injury in chronic pressure ulcer formation: a skin model in the rat. Wound Repair Regen. 2000;8:68–76
  12. Miller GE, Seale J. Lymphatic clearance during compressive loading. Lymphology. 1981;14:161–166
  13. Pialoux V, Mounier R, Brown AD, Steinback CD, Rawling JM, Poulin MJ. Relationship between oxidative stress and HIF-1 alpha mRNA during sustained hypoxia in humans. Free Radic Biol Med. 2009;46:321–326
  14. Wardman P. Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia. Curr Med Chem. 2001;8:739–761
  15. Thorfinn J, Sjoberg F, Lidman D. Sitting can cause ischaemia in the subcutaneous tissue of the buttocks, which implicates multilayer tissue damage in the development of pressure ulcers. Scand J Plast Reconstr Surg Hand Surg. 2009;43:82–89
  16. Gawlitta D, Oomens CW, Bader DL, Baaijens FP, Bouten CV. Temporal differences in the influence of ischemic factors and deformation on the metabolism of engineered skeletal muscle. J Appl Phys. 2007;103:464–473
  17. Gawlitta D, Li W, Oomens CW, Baaijens FP, Bader DL, Bouten CV. The relative contributions of compression and hypoxia to development of muscle tissue damage: an in vitro study. Ann Biomed Eng. 2007;35:273–284
  18. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 1995;92:5510–5514
  19. Sutter CH, Laughner E, Semenza GL. Hypoxia-inducible factor 1-alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc Natl Acad Sci U S A. 2000;97:4748–4753
  20. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;292:464–468
  21. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang G-W, Clifford SC, et al. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel–Lindau tumor suppressor protein. J Biol Chem. 2000;275:25733–25741
  22. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468–472
  23. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 2006;70:1469–1480
  24. Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev. 2000;14:1983–1991
  25. Sari Y. Hypoxia is involved in deep tissue injury formation in a rat model. In: Masters thesis, The University of Tokyo Graduate School of Medicine; 2009.
  26. Sugama J, Sanada H, Nakatani T, Nagakawa T, Inagaki M. Pressure-induced ischemic wound healing with bacterial inoculation in the rat. Wounds. 2005;17:157–168
  27. Botusan IR, Sunkari VG, Savu O, Catrina AI, Grünler J, Lindberg S, et al. Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci U S A. 2008;105:19426–19431
  28. Tanaka T, Hanafusa N, Ingelfinger JR, Ohse T, Fujita T, Nangaku M. Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-mediated upregulation of Bax. Biochem Biophys Res Commun. 2003;309:222–231
  29. Bakker WJ, Harris IS, Mak TW. FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2. Mol Cell. 2007;28:941–953
  30. Fitsialos G, Bourget I, Augier S, Ginouvès A, Rezzonico R, Odorisio T, et al. HIF1 transcription factor regulates laminin-332 expression and keratinocyte migration. J Cell Sci. 2008;121:2992–3001
  31. Giatromanolaki A, Fiska A, Pitsiava D, Kartalis G, Koukourakis MI, Sivridis E. Erythropoietin receptors in endometrial carcinoma as related to HIF1α and VEGF expression. In Vivo. 2009;23:699–703
  32. Dawson DM, Eppenberger HM, Eppenberger ME. Multiple molecular forms of creatine kinases. Ann N Y Acad Sci. 1968;151:616–626
  33. Miyoshi K, Ohshima I, Ohto Y, Matsuoka M, Kawai H. Theoretical analysis of creatine kinase isozyme patterns in various human tissues and myopathic skeletal muscles. Tokushima J Exp Med. 1974;21:75–78
  34. Schneider CM, Dennehy CA, Rodearmel SJ, Hayward JR. Effects of physical activity on creatine phosphokinase and the isoenzyme creatine kinase-MB. Ann Emerg Med. 1995;25:520–524
  35. Somer H, Donner M, Murros J, Konttinen A. A serum isozyme study in muscular dystrophy. Particular reference to creatine kinase, aspartate aminotransferase, and lactic acid dehydrogenase isozymes. Arch Neurol. 1973;29:343–345
  36. Chen LH, Thacker RR. Plasma creatine kinase isozyme electrophoretic pattern of long-term vitamin E-deficient rats. Int J Vitam Nutr Res. 1983;53:138–142
  37. Hagisawa S, Ferguson-Pell MW, Palmieri VR, Cochran GV. Pressure sores: a biochemical test for early detection of tissue damage. Arch Phys Med Rehabil. 1988;69:668–671
  38. Sari Y, Nakagami G, Kinoshita A, Huang L, Ueda K, Iizaka S, et al. Changes in serum and exudate creatine phosphokinase concentrations as an indicator of deep tissue injury: a pilot study. Int Wound J. 2008;5:674–680
  39. National Pressure Ulcer Advisory Panel . Updated staging system: pressure ulcer stages revised by NPUAP. http://www.npuap.org/pr2.htm2007;[accessed 6.10.09]
  40. Shea JD. Pressure sores: classification and management. Clin Orthop Relat Res. 1975;112:89–100
  41. Siu PM, Tam EW, Teng BT, Pei XM, Ng JW, Benzie IF, et al. Muscle apoptosis is induced in pressure-induced deep tissue injury. J Appl Phys. 2009;doi:10.1152/japplphysiol.90897.2008

PII: S0965-206X(09)00050-3

doi: 10.1016/j.jtv.2009.10.004

Journal of Tissue Viability
Volume 19, Issue 2 , Pages 77-83 , May 2010

Article Tools

* Image Usage & Resolution